Gilenya, Jevtana ANDA filings lift Natco
This article was originally published in Scrip
Executive Summary
Shares of Natco Pharma spurted on Indian bourses after the firm said that it had, through its partners, filed ANDAs with the US FDA for fingolimod 0.5mg capsules and cabazitaxel 60mg/1.5ml injection, generic versions of Novartis's Gilenya and Sanofi's Jevtana respectively.